![]() |
![]() |
Legal status
Patent in force
(51) | INT.CL. | C07D 487/04 | (2006.01) |
A61K 31/519 | (2006.01) | ||
A61P 29/00 | (2006.01) | ||
A61P 25/00 | (2006.01) | ||
A61P 11/00 | (2006.01) | ||
A61P 33/00 | (2006.01) | ||
A61P 35/00 | (2006.01) |
(11) | Number of the document | 3475282 |
(13) | Kind of document | T |
(96) | European patent application number | 17731149.5 |
Date of filing the European patent application | 2017-06-20 | |
(97) | Date of publication of the European application | 2019-05-01 |
(45) | Date of publication and mention of the grant of the patent | 2023-08-09 |
(46) | Date of publication of the claims translation |
(86) | Number | PCT/EP2017/064994 |
Date | 2017-06-20 |
(87) | Number | WO 2017/220517 |
Date | 2017-12-28 |
(30) | Number | Date | Country code |
16175924 | 2016-06-23 | EP |
(72) |
GOBBI, Luca , CH
GRETHER, Uwe , CH
GUBA, Wolfgang , CH
KRETZ, Julian , CH
MARTIN, Rainer E. , CH
WESTPHAL, Matthias Valentin , CH
IJZERMAN, Adriaan Pieter , NL
|
(73) |
F. Hoffmann-La Roche AG ,
Grenzacherstrasse 124, 4070 Basel,
CH
|
(54) | [1,2,3]TRIAZOLO[4,5-D]PYRIMIDINE DERIVATIVES WITH AFFINITY FOR THE TYPE-2 CANNABINOID RECEPTOR |
[1,2,3]TRIAZOLO[4,5-D]PYRIMIDINE DERIVATIVES WITH AFFINITY FOR THE TYPE-2 CANNABINOID RECEPTOR |